BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, November 27, 2024
Breaking News: Healing a health divide (that’s long overdue)
See today's BioWorld Science
Home
» YAP targeting may reverse primary ovarian insufficiency
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Genitourinary/Sexual Function
YAP targeting may reverse primary ovarian insufficiency
Oct. 11, 2022
No Comments
Primary ovarian insufficiency (POI) is a clinical syndrome characterized by premature exhaustion of the resting pool of primordial follicles before the age of 40 years in women; the mechanism of follicular depletion is not well understood.
BioWorld Science
Genitourinary/sexual function